Devlife Corporation Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Devlife Corporation Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $123.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Devlife Corporation Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $123.1K Trade | TransData Nexus

Devlife Corporation Private Limited

Indian Pharmaceutical Exporter · Antiviral & HIV Medications Specialist · $123.1K Total Trade · DGFT Verified

Devlife Corporation Private Limited is an Indian pharmaceutical exporter with a total trade value of $123.1K across 2 products in 2 therapeutic categories. Based on 9 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Sofosbuvir ($91.7K), Benzylpenicillin ($31.4K), .

Devlife Corporation Private Limited — Export Portfolio & Destination Treemap

Devlife Corporation Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Devlife Corporation Private Limited? — Company Overview & Market Position

Devlife Corporation Private Limited, established in 2005, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company specializes in the development, manufacturing, and marketing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Devlife Corporation is accredited with the World Health Organization's Good Manufacturing Practices (WHO GMP) certification, ensuring adherence to international quality standards.

The company's Corporate Identification Number (CIN) is U85100MH2020PTC342762, and it is registered under the Registrar of Companies, Mumbai. Devlife Corporation operates as a private limited company with an authorized share capital of ₹1,500,000 and a paid-up capital of ₹300,000. The registered office is located at Off No.912, 9th Floor, J Wing, CTS No 1/7 V. S, Marg, Vikhroli Park site, Vikhroli, Maharashtra, India - 400079.

What Does Devlife Corporation Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Sofosbuvir$91.7K 2

Product Portfolio — Top 2 by Export Value

Devlife Corporation Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Sofosbuvir	Antiviral & HIV Medications	$91.7K	3	0.2%	13
2	Benzylpenicillin	Advanced Antibiotics	$31.4K	6	0.8%	10

Devlife Corporation Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $123.1K. The top category is Antiviral & HIV Medications (74.5% of portfolio), followed by Advanced Antibiotics (25.5%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Devlife Corporation Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Devlife Corporation operates a state-of-the-art manufacturing facility in Gujarat, India, which maintains high-quality standards and processes. The plant is equipped to produce a diverse range of pharmaceutical products, including tablets, capsules, liquid orals, soft gelatin capsules, ophthalmic preparations, liquid ampoules, dry powder vials, creams, and ointments.

3Key Leadership

The leadership team at Devlife Corporation includes:

Mr. R.R. Bhatia: Director

Ms. Vaishali Anjaria: Director

Ms. Roopa Ramesh: Director

Ms. Jayashri Jayraj: Director

These individuals collectively guide the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Devlife Corporation Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Devlife Corporation has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports finished pharmaceutical formulations to countries such as the United Kingdom, Philippines, Nepal, Egypt, and Canada. While specific regulatory filings and approvals in these markets are not publicly disclosed, the company's adherence to WHO GMP standards suggests compliance with international regulatory requirements.

2Emerging Markets

Devlife Corporation has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's WHO GMP certification facilitates access to these regions, enabling it to meet the quality standards required for market entry.

3Geographic Strategy

Devlife Corporation's export activities indicate a strategic focus on both developed and emerging markets. The company's portfolio concentration, with its top two products accounting for 100% of export value, suggests a targeted approach to product offerings. This strategy may mitigate risks associated with market diversification while capitalizing on established demand for specific products.

Devlife Corporation Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Devlife Corporation's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's WHO GMP certification indicates a commitment to quality standards recognized internationally, which may support its operations in the U.S. market.

2WHO & EU GMP

Devlife Corporation holds WHO GMP certification, reflecting its adherence to international manufacturing standards. While the company is WHO GMP certified, specific details regarding EU GMP certificates and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed.

3CDSCO & Indian Regulatory

Devlife Corporation operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Specific details regarding export No Objection Certificates (NOCs) are not publicly available.

Devlife Corporation Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Devlife Corporation operates in a competitive pharmaceutical industry, facing competition from both domestic and international manufacturers. While specific competitors in overlapping categories are not identified, the company's focus on finished pharmaceutical formulations positions it in competition with other manufacturers offering similar products. The company's export activities to various countries indicate a competitive presence in multiple markets.

2Key Differentiators

Devlife Corporation's key differentiators include its WHO GMP certification, indicating adherence to international quality standards, and its focus on customized finished formulations. The company's manufacturing facility in Gujarat is equipped to produce a diverse range of pharmaceutical products, enhancing its ability to meet various market demands.

3Strategic Position

Devlife Corporation's strategic direction appears to focus on the development and export of finished pharmaceutical formulations, leveraging its WHO GMP certification to access both regulated and emerging markets. The company's portfolio concentration suggests a targeted approach to product offerings, potentially reducing risks associated with market diversification. Future strategic initiatives may involve expanding its product portfolio and enhancing its presence in additional international markets.

Buyer Due Diligence Brief — Evaluating Devlife Corporation Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Devlife Corporation demonstrates a commitment to quality through its WHO GMP certification and adherence to good manufacturing practices. The company's export volume, with a total export value of $123,000 USD across nine shipments, indicates a consistent approach to international trade. Reliability indicators, such as on-time delivery and product quality, are not publicly disclosed but are implied by the company's regulatory certifications and market presence.

2Certifications to Verify

Importers should verify the following certifications when considering Devlife Corporation as a supplier:

WHO GMP Certification: Confirms adherence to international manufacturing standards.

FDA Facility Registration: Indicates compliance with U.S. regulatory requirements.

EU GMP Certification: Demonstrates compliance with European manufacturing standards.

Frequently Asked Questions — Devlife Corporation Private Limited

How many pharmaceutical products does Devlife Corporation Private Limited export from India?

Devlife Corporation Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Sofosbuvir ($91.7K), Benzylpenicillin ($31.4K). Total export value is $123.1K.

What is Devlife Corporation Private Limited's total pharmaceutical export value?

Devlife Corporation Private Limited's total pharmaceutical export value is $123.1K, based on 9 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Devlife Corporation Private Limited cover?

Devlife Corporation Private Limited exports across 2 therapeutic categories. The largest are Antiviral & HIV Medications (74.5%, 1 products), Advanced Antibiotics (25.5%, 1 products).

Get Full Devlife Corporation Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.